Princeton Portfolio Strategies Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $2.27M | Sell |
58,100
-2,038
| -3% | -$79.3K | 0.44% | 55 |
|
|
2021
Q1 | $2.18M | Sell |
60,138
-1,325
| -2% | -$47K | 0.42% | 64 |
|
|
2020
Q4 | $2.26M | Sell |
61,463
-3,424
| -5% | -$126K | 0.45% | 54 |
|
|
2020
Q3 | $2.26M | Buy |
64,887
+2,079
| +3% | +$72.9K | 0.49% | 49 |
|
|
2020
Q2 | $1.95M | Sell |
62,808
-3,419
| -5% | -$116K | 0.47% | 57 |
|
|
2020
Q1 | $2.05M | Buy |
66,227
+484
| +0.7% | +$16.5K | 0.6% | 44 |
|
|
2019
Q4 | $2.44M | Buy |
65,743
+4,216
| +7% | +$150K | 0.58% | 49 |
|
|
2019
Q3 | $2.1M | Hold |
61,527
| – | – | 0.52% | 52 |
|
|
2019
Q2 | $2.53M | Sell |
61,527
-95
| -0.2% | -$3.77K | 0.64% | 43 |
|
|
2019
Q1 | $2.48M | Sell |
61,622
-7,674
| -11% | -$307K | 0.66% | 43 |
|
|
2018
Q4 | $2.87M | Sell |
69,296
-1,038
| -1% | -$43.1K | 0.89% | 40 |
|
|
2018
Q3 | $2.94M | Sell |
70,334
-2,984
| -4% | -$115K | 0.76% | 44 |
|
|
2018
Q2 | $2.52M | Sell |
73,318
-11,557
| -14% | -$395K | 0.73% | 44 |
|
|
2018
Q1 | $2.86M | Buy |
84,875
+1,441
| +2% | +$49.5K | 0.81% | 45 |
|
|
2017
Q4 | $2.87M | Buy |
83,434
+8,071
| +11% | +$275K | 0.78% | 46 |
|
|
2017
Q3 | $2.55M | Buy |
75,363
+843
| +1% | +$27.1K | 0.69% | 52 |
|
|
2017
Q2 | $2.38M | Buy |
74,520
+2,589
| +4% | +$81.6K | 0.68% | 54 |
|
|
2017
Q1 | $2.33M | Buy |
71,931
+3,403
| +5% | +$107K | 0.69% | 52 |
|
|
2016
Q4 | $2.11M | Buy |
68,528
+3,842
| +6% | +$117K | 0.67% | 54 |
|
|
2016
Q3 | $2.08M | Sell |
64,686
-211
| -0.3% | -$7.05K | 0.65% | 51 |
|
|
2016
Q2 | $2.17M | Buy |
64,897
+534
| +0.8% | +$17K | 0.7% | 50 |
|
|
2016
Q1 | $1.81M | Sell |
64,363
-953
| -1% | -$27.2K | 0.61% | 54 |
|
|
2015
Q4 | $2M | Buy |
65,316
+38,636
| +145% | +$1.22M | 0.71% | 52 |
|
|
2015
Q3 | $795K | Sell |
26,680
-2,187
| -8% | -$70.1K | 0.32% | 73 |
|
|
2015
Q2 | $918K | Buy |
28,867
+10,697
| +59% | +$349K | 0.32% | 75 |
|
|
2015
Q1 | $600K | Hold |
18,170
| – | – | 0.23% | 86 |
|
|
2014
Q4 | $537K | Sell |
18,170
-4,927
| -21% | -$141K | 0.21% | 92 |
|
|
2014
Q3 | $648K | Hold |
23,097
| – | – | 0.27% | 86 |
|
|
2014
Q2 | $650K | Buy |
23,097
+8,562
| +59% | +$244K | 0.28% | 89 |
|
|
2014
Q1 | $443K | Sell |
14,535
-253
| -2% | -$7.54K | 0.29% | 87 |
|
|
2013
Q4 | $430K | Buy |
14,788
+60
| +0.4% | +$1.75K | 0.29% | 84 |
|
|
2013
Q3 | $401K | Buy |
14,728
+6,724
| +84% | +$183K | 0.3% | 83 |
|
|
2013
Q2 | $213K | Buy |
+8,004
| New | +$221K | 0.17% | 98 |
|
Other funds holding PFE
Princeton Portfolio Strategies Group's PFE Position: Q2 2021 in Review
Princeton Portfolio Strategies Group reduced its Pfizer (PFE) stake by 3.4% in Q2 2021, selling an estimated $79.3K and leaving 58,100 shares worth $2.27M. The position accounts for 0.44% of the portfolio, ranked #55.
Princeton Portfolio Strategies Group first reported a position in PFE in Q2 2013 and has held it in 33 quarters since. The position peaked at $2.94M in Q3 2018. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.
- Princeton Portfolio Strategies Group held 58,100 shares of Pfizer worth $2.27M as of Q2 2021.
- Princeton Portfolio Strategies Group sold 2,038 Pfizer shares in Q2 2021, an estimated $79.3K.
- Pfizer made up 0.44% of Princeton Portfolio Strategies Group's portfolio in Q2 2021, its #55 holding.
- Princeton Portfolio Strategies Group first reported a position in Pfizer in Q2 2013 and has held it in 33 quarters since.
- Princeton Portfolio Strategies Group's Pfizer position peaked at $2.94M in Q3 2018.
- 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.
Based on Princeton Portfolio Strategies Group's 13F filing for Q2 2021, filed 2 Aug 2021.